Skip to main content

Table 3 Data extract of SAA expression in control and cancer patients

From: Increased serum amyloid A as potential diagnostic marker for lung cancer: a meta-analysis based on nine studies

Author

Concentration of SAA (Mean ± standard deviation)

Positive /all (N)

Diagnostic test (2 × 2 table)

Control

All cancer cases

LAC

LSCC

SCLC

Control

Lung cancer

TP

FP

FN

TN

Benson MD [12]

135 ± 31

1880 ± 251

1460 ± 494

1923 ± 317

1118 ± 317

14/50

45/50

45

14

5

36

Howard BA [13]

34.1

286

NA

NA

NA

1/15

15/19

15

1

4

14

Khan N [14]

43.8 ± 9.65

83.5 ± 19.5

NA

NA

NA

4/25

14/25

14

4

11

21

Dai S [16]

2.15 ± 0.73

18.48 ± 21.22

NA

NA

NA

NA

NA

NA

NA

NA

NA

Liu DH [17]

2.1 ± 0.7

19.3 ± 20.6

15.1 ± 22.4

34.3 ± 20.2

25.7 ± 26

0/82

95/193

95

0

98

82

Cho WC [15]

0.109 ± 0.033

1.872 ± 0.212

NA

NA

NA

NA

NA

NA

NA

NA

NA

 

17.06 ± 2.55

710.77 ± 250.42

         

Sung HJ [4]

13.89 ± 37.18

190.49 ± 234.70

190.49 ± 134.70

302.76 ± 305.21

116.38 ± 81.13

7/140

90/170

90

7

80

133

Dowling P [18]

9.8

NA

141.6

54.8

172.2

NA

NA

NA

NA

NA

NA

Kanoh Y [9]

8.2 ± 10.55

158 ± 448.7

NA

NA

NA

0/13

24/24

24

0

0

13

  1. N, cases; NA, unavailable; true positive; LAC lung adenocarcinoma; LSCC lung squamous cell carcinoma; SCLC small cell lung cancer; FP false positive; FN false negative; TN true negative